MENU
GLMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Galmed Pharmaceuticals (GLMD) Ownership - Who owns Galmed Pharmaceuticals?

Galmed Pharmaceuticals Ltd is a biopharmaceutical company... Show more

Profile

Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.82M
P/E Ratio
0.02
Total Cash
19.05M
Projected Growth
N/A
Total Debt
41K
Revenue
N/A
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash/Share
3.48
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GLMD
Capitalization
4.82M
P/E Ratio
0.02
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash
19.1M
Total Cash/Share
3.48
Total Debt
41K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
19.1M
P/B Ratio
0.25
Cash Flow
N/A
Earnings
-3.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.79M
Current Ratio
7.98
Current Revenue Per Employee
88235.30
Dividends Per Share - Security
N/A
EBITDA
-7.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.91
Shares Held By Institutions
104K
Shares Outstanding - Current
5.48M
Total Liabilities
2.47M
Total Volume MTD
N/A
Value
1
Gain YTD
-72.404
View a ticker or compare two or three
GLMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GLMD showed earnings on November 26, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com